<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Ra Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Ra Pharmaceuticals, Inc.

    Ra PharmaÂŽ is a clinical-stage biopharmaceutical company using a proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system, a critical component of the immune system. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Douglas Treco, Ph.D.
    • FOUNDED
      2008
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    DENTSPLY SIRONA Inc.

    DENTSPLY SIRONA Inc.

    Dentsply Sirona is the world’s largest manufacturer of professional dental produ...

    Dentsply Sirona is the world’s largest manufa...

    Filing Type:    PU
    Phormed Inc

    Phormed Inc

    PhorMed is a clinical stage biopharmaceutical company located in Beverly Hills Cal...

    PhorMed is a clinical stage biopharmaceutical c...

    Amount Raised:    $128,700.00
    Fundraising Status:    EC
    Filing Type:    CF
    TrovaGene, Inc.

    TrovaGene, Inc.

    Trovagene is a clinical-stage, oncology therapeutics company, taking a precision m...

    Trovagene is a clinical-stage, oncology therape...

    Filing Type:    PU
    Aurinia Pharmaceuticals Inc

    Aurinia Pharmaceuticals Inc

    Aurinia is a late clinical stage biopharmaceutical company focused on developing a...

    Aurinia is a late clinical stage biopharmaceuti...

    Filing Type:    PU
    NeuBase Therapeutics, Inc.

    NeuBase Therapeutics, Inc.

    NeuBase Therapeutics, Inc. is developing its modular peptide-nucleic acid antisens...

    NeuBase Therapeutics, Inc. is developing its mo...

    Filing Type:    PU
    Arbutus Biopharma Corporation

    Arbutus Biopharma Corporation

    Arbutus Biopharma is a publicly-traded (NASDAQ:ABUS) biopharmaceutical company ded...

    Arbutus Biopharma is a publicly-traded (NASDAQ:...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.